Burnham-on-Sea minor injuries unit to move on trial basis
He said the unit helps give patients the right support, frees up emergency departments and allows staff to prioritise people with the most serious health conditions."We're very committed to the teams and services that run the minor injuries unit in Burnham-on-Sea and we know how important these are for local communities," Mr Heron said. "We are working with our primary and secondary care teams to consider different ways to deliver a more integrated and resilient same-day urgent care service for local people."The service will be open seven days a week from 10:00 to 18:00 GMT for residents.Mr Heron added: "Over the coming weeks, our teams will continue to work through the detail of this proposal, and we will update our teams, local people and partners".
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BreakingNews.ie
03-08-2025
- BreakingNews.ie
Singer Jessie J returned to hospital with ‘infection' and ‘fluid on my lungs'
Singer Jessie J has revealed she returned to hospital where an 'infection' and 'a little fluid' on her lungs were discovered. The 37-year-old, whose real name is Jessica Cornish, said she has since discharged herself from the hospital where she was treated after breast cancer surgery just weeks ago, revealing in July that she had since seen 'no cancer spread'. Advertisement In a post on Instagram, the Price Tag singer said: 'Six weeks post surgery and I was back in the same ward I was after my surgery. Not expected or planned. 'I had and still have symptoms that pointed towards a blood clot on the lung, it is not a blood clot thank god. 'They ran a lot of tests, which ended up showing I have an infection (still trying to figure out what) and a little fluid on my lungs. Jessie J said the hospital visit was a 'reminder to myself to slow down' (Jordan Pettitt/PA) 'Finding it hard to breathe in, but I discharged myself last night (I hate being in hospital) and will continue the investigation as an outpatient.' Advertisement She went on to say it was 'frustrating' that her career plans had to change due to her surgery and hospital visits, and added that she had been 'working so hard to get to this point and excited to do it all'. Cornish said: 'I know for me, the true hard journey of this whole thing physically was the day I went into surgery. 'The recovery physically is far from quick or easy, and mentally it's been the most challenging time for me, especially as a mum with a toddler and being unable to be the mother I usually am.' The star said her visit to hospital was a 'reminder to myself to slow down' even though she felt she was already at a slow pace. Advertisement Cornish added: 'This isn't a speedy recovery and it isn't meant to be. 'As an ADHD Aries, fire breathing dragon t-rex, I can do it myself, I'm always ok woman. That slow pace has been a hard reality to accept to be honest. 'I love moving and working and being up and active but I can't be right now, and that's what it is, and I am finding the strength knowing that all can be adjusted to align with a slower pace and the support of my very small inner support circle.' The London-born singer welcomed her son, Sky Safir Cornish Colman, in 2023, having had a miscarriage in November 2021. Advertisement She has battled with ill-health throughout her life, having been diagnosed with a heart condition aged eight, suffering a minor stroke aged 18 and having briefly gone deaf in 2020. The singer-songwriter has had three number one songs in the UK singles chart with Domino, Price Tag and Bang Bang. She was awarded four Mobo awards in 2011 including best UK act, best newcomer, best song for Do It Like A Dude and best album with Who You Are, and won the Brit Award for rising star in 2011.
The Independent
03-08-2025
- The Independent
Singer Jessie J returned to hospital with ‘infection' and ‘fluid on my lungs'
Singer Jessie J has revealed she returned to hospital where an 'infection' and 'a little fluid' on her lungs were discovered. The 37-year-old, whose real name is Jessica Cornish, said she has since discharged herself from the hospital where she was treated after breast cancer surgery just weeks ago, revealing in July that she had since seen 'no cancer spread'. In a post on Instagram, the Price Tag singer said: 'Six weeks post surgery and I was back in the same ward I was after my surgery. Not expected or planned. 'I had and still have symptoms that pointed towards a blood clot on the lung, it is not a blood clot thank god. 'They ran a lot of tests, which ended up showing I have an infection (still trying to figure out what) and a little fluid on my lungs. 'Finding it hard to breathe in, but I discharged myself last night (I hate being in hospital) and will continue the investigation as an outpatient.' She went on to say it was 'frustrating' that her career plans had to change due to her surgery and hospital visits, and added that she had been 'working so hard to get to this point and excited to do it all'. Cornish said: 'I know for me, the true hard journey of this whole thing physically was the day I went into surgery. 'The recovery physically is far from quick or easy, and mentally it's been the most challenging time for me, especially as a mum with a toddler and being unable to be the mother I usually am.' The star said her visit to hospital was a 'reminder to myself to slow down' even though she felt she was already at a slow pace. Cornish added: 'This isn't a speedy recovery and it isn't meant to be. 'As an ADHD Aries, fire breathing dragon t-rex, I can do it myself, I'm always ok woman. That slow pace has been a hard reality to accept to be honest. 'I love moving and working and being up and active but I can't be right now, and that's what it is, and I am finding the strength knowing that all can be adjusted to align with a slower pace and the support of my very small inner support circle.' The London-born singer welcomed her son, Sky Safir Cornish Colman, in 2023, having had a miscarriage in November 2021. She has battled with ill-health throughout her life, having been diagnosed with a heart condition aged eight, suffering a minor stroke aged 18 and having briefly gone deaf in 2020. The singer-songwriter has had three number one songs in the UK singles chart with Domino, Price Tag and Bang Bang. She was awarded four Mobo awards in 2011 including best UK act, best newcomer, best song for Do It Like A Dude and best album with Who You Are, and won the Brit Award for rising star in 2011.
Reuters
29-07-2025
- Reuters
AstraZeneca seeks US drug price cuts amid expansion plans, strong demand
July 29 (Reuters) - AstraZeneca (AZN.L), opens new tab has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 billion investment to expand there, as President Donald Trump pressures pharmaceuticals companies to lower costs. Speaking to journalists after second-quarter revenue and profit beat expectations, CEO Pascal Soriot said Trump's administration was reviewing the company's proposals. He did not specify which drugs were included. Trump has repeatedly threatened tariffs as he also pushes drugmakers to reduce prices to what other countries pay. However, he signalled earlier this month that companies would be given a year to 18 months to "get their act together" before any sector-specific levies take effect. "We definitely support the idea of rebalancing with some reduction of pricing levels in the U.S., and some increase, we're not talking about massive increases, in Europe," AstraZeneca's Soriot said. He added he expects all medicines for U.S. patients to be produced locally within a few months, and is also considering selling some medicines to customers directly. AstraZeneca shares rose as much as 3% after its results, but pared some gains to trade up 1.6% by 1214 GMT. "The big uncertainty, unsurprisingly, remains U.S. tariffs and Most Favoured Nation pricing in the pharmaceutical sector. AstraZeneca has looked to get ahead of this uncertainty," said Sheena Berry, a healthcare analyst at Quilter Cheviot. The U.S. accounted for more than 40% of AstraZeneca's revenue in 2024. The UK's largest-listed company by market value had prioritised the U.S. market - the world's largest, worth $635 billion - even before Trump's return to office. AstraZeneca's efforts are paying off as strong U.S. demand, and robust sales of newer cancer, heart and kidney disease medicines drove total revenue for the second quarter 11% higher to $14.46 billion, on a constant currency basis. It logged double-digit growth in the U.S. despite headwinds from changes in U.S. Medicare price negotiations, while sales of cancer drugs including Tagrisso, Lynparza, Calquence, Truqap and Imfinzi beat expectations. Core earnings stood at $2.17 per share. Analysts were expecting $2.16, from $14.15 billion in sales, according to a company-provided consensus. AstraZeneca is betting on a wave of expected launches of 20 new medicines and its U.S. expansion to reach $80 billion in annual revenue by 2030 and offset generic competition. On Tuesday, it maintained its 2025 outlook and increased its interim dividend by 3%. The drugmaker in April forecast only a limited impact from potential U.S. tariffs, adding it would be able to meet its annual outlook if the levies on European imports were similar to those in other industries. A European Union-U.S. trade deal over the weekend will result in a 15% tariff on most goods, including pharmaceuticals, from the region.
